NORTHERN TRUST CORP - FORMA THERAPEUTICS HLDGS INC ownership

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of FORMA THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q3 2022$6,993,000
+192.5%
350,530
+1.0%
0.00%
+100.0%
Q2 2022$2,391,000
-17.3%
346,990
+11.6%
0.00%0.0%
Q1 2022$2,891,000
-35.1%
310,816
-0.7%
0.00%0.0%
Q4 2021$4,453,000
-37.2%
313,109
+2.4%
0.00%0.0%
Q3 2021$7,091,000
-1.1%
305,779
+6.2%
0.00%0.0%
Q2 2021$7,169,000
-13.9%
288,055
-3.0%
0.00%
-50.0%
Q1 2021$8,323,000
+16.4%
297,053
+45.0%
0.00%
+100.0%
Q4 2020$7,150,000
-23.0%
204,897
+10.0%
0.00%
-50.0%
Q3 2020$9,287,000186,3320.00%
Other shareholders
FORMA THERAPEUTICS HLDGS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,565,529$43,866,0008.09%
Logos Global Management LP 1,410,000$39,508,0003.86%
RA Capital Management 9,011,651$252,506,0003.81%
Cormorant Asset Management, LP 4,720,000$132,254,0002.95%
Artal Group S.A. 1,000,000$28,020,0000.50%
Perceptive Advisors 1,250,000$35,025,0000.44%
HighVista Strategies LLC 20,630$578,0000.43%
HHLR ADVISORS, LTD. 1,100,000$30,822,0000.30%
Baker Brothers Advisors 2,024,876$56,737,0000.25%
Tekla Capital Management LLC 149,825$4,198,0000.14%
View complete list of FORMA THERAPEUTICS HLDGS INC shareholders